Nomination Committee appointed in respect of AGM 2018 in Oncopeptides
Stockholm - October 17, 2017 - According to the principles for the appointment of the Nomination Committee in Oncopeptides AB adopted at the annual general meeting held on 18 May 2017, the Nomination Committee for the annual general meeting 2018 shall be composed of members appointed by the three largest shareholders in terms of voting rights as of 30 September, along with the Chairman of the Board of Directors.The composition of the Nomination Committee has now been established, and Oncopeptides today announced that the Nomination Committee in respect of the annual general meeting 2018